Nodal status at repeat mediastinoscopy determines survival in non-small cell lung cancer with mediastinal nodal involvement, treated by induction therapy

European Journal of Cardio-thoracic Surgery

Volumn 29, Issue 2, 2006, Pages 240-243

  De Waele, Michèle ^a   Hendriks, Jeroen ^a   Lauwers, Patrick ^a   Ortmanns, Paul ^b   Vanroelen, Wim ^c   Morel, Ann Marie ^d   Germonpré, Paul ^a   Van Schil, Paul ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b Hospital AZ Heilige Familie   (Belgium)

^c Department of Pulmonary Medicine   (Belgium)

^d Department of Pulmonary Medicine   (Belgium)

Author keywords

Induction therapy; Lung cancer; Remediastinoscopy; Staging

Indexed keywords

CISPLATIN;

ADULT; AGED; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MALE; MEDIASTINOSCOPY; MEDIASTINUM LYMPH NODE; PRIORITY JOURNAL; PROGNOSIS; THORACOTOMY;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MEDIASTINOSCOPY; MIDDLE AGED; NEOPLASM STAGING; POSTOPERATIVE PERIOD; PROGNOSIS; REMISSION INDUCTION; SURVIVAL ANALYSIS;

EID: 31044448177     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2005.10.045     Document Type: Conference Paper

References (21)

1. P.E. Van Schil, R.H. Van Hee, and E.L. Schoofs The value of mediastinoscopy in preoperative staging of bronchogenic carcinoma J Thorac Cardiovasc Surg 97 1989 240 244
2. M. Pauwels, P. Van Schil, W. De Backer, F. Van den Brande, and E. Eyskens Repeat mediastinoscopy in the staging of lung cancer Eur J Cardiothorac Surg 14 1998 271 273
3. D. Meersschaut, F. Vermassen, A. Brutel de la Rivière, P.J. Knaepen, J.M. Van den Bosch, and R. Vanderschueren Repeat mediastinoscopy in the assessment of new and recurrent lung neoplasm Ann Thorac Surg 53 1992 120 122
4. P.S. Olsen, P. Stentoft, B. Ellefsen, and G. Pettersson Re-mediastinoscopy in the assessment of resectability of lung cancer Eur J Cardiothorac Surg 11 1997 661 663
5. P. Van Schil The restaging issue Lung Cancer 42 2003 S39 S45
6. P. Van Schil, J. van der Schoot, J. Poniewierski, M. Pauwels, L. Carp, P. Germonpre, and W. De Backer Remediastinoscopy after neoadjuvant therapy for non-small cell lung cancer Lung Cancer 37 2002 281 285
7. M. Mateu-Navarro, R. Rami-Porta, R. Bastus-Piulats, L. Cirera-Nogueras, and G. Gonzalez-Pont Remediastinoscopy after induction chemotherapy in non-small cell lung cancer Ann Thorac Surg 70 2000 391 395
8. M. Mateu-Navarro, R. Rami-Porta, and M. Sera-Mitjans Preliminary survival analysis of patients with non-small cell lung cancer after induction therapy followed by surgical restaging and lung resection or palliative treatment Lung Cancer 41 2003 S190
9. T. Naruke, K. Suemasu, and S. Ishikawa Lymph node mapping and curability at various levels of metastasis in resected lung cancer J Thorac Cardiovasc Surg 76 1978 832 839
10. A. Gdeedo, P. Van Schil, B. Corthouts, F. Van Mieghem, J. Van Meerbeeck, and E. Van Marck Prospective evaluation of computed tomography and mediastinoscopy in mediastinal lymph node staging Eur Respir J 10 1997 1547 1551
11. A. Gdeedo, P. Van Schil, B. Corthouts, F. Van Mieghem, J. Van Meerbeeck, and E. Van Marck Comparison of imaging TNM (iTNM) and pathological (pTNM) in staging of bronchogenic carcinoma Eur J Cardiothorac Surg 12 1997 224 227
12. U. Haberkorn Positron emission tomography (PET) of non-small cell lung cancer Lung Cancer 34 2001 S115 S121
13. T. Akhurst, R.J. Downey, M.S. Ginsberg, M. Gonen, M. Bains, R. Korst, R.J. Ginsberg, V.W. Rusch, and S.M.I. Larson An initial experience with FDG-PET in the imaging of residual disease after induction therapy for lung cancer Ann Thorac Surg 73 2002 259 266
14. J.F. Vansteenkiste, S.G. Stroobants, P.R. De Leyn, P.J. Dupont, J. Bogaert, A. Maes, G.J. Deneffe, K.L. Nackaerts, J.A. Verschakelen, T.E. Lerut, L.A. Mortelmans, and M.G. Demedts Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients J Clin Oncol 16 1998 2142 2149
15. J.L. Port, M.S. Kent, R.J. Korst, R. Keresztes, M.A. Levin, and N.K. Altorki Positron emission tomography poorly predicts response to preoperative chemotherapy in non-small cell lung cancer Ann Thorac Surg 77 2004 254 259
16. L.K. Shankar, and D.C. Sullivan Functional imaging in lung cancer J Clin Oncol 23 2005 3203 3211
17. R. Bueno, W.G. Richards, S.J. Swanson, M.T. Jaklitsch, J.M. Lukanich, S.J. Mentzer, and D.J. Sugarbaker Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival Ann Thorac Surg 70 2000 1826 1831
18. L. Voltolini, L. Luzzi, C. Ghiribelli, P. Paladini, M. Di Bisceglie, and G. Gotti Results of induction chemotherapy followed by surgical resection in patients with stage IIIA (N2) non-small cell lung cancer: the importance of the nodal down-staging after chemotherapy Eur J Cardiothorac Surg 20 2001 1106 1112
19. S. Rooker, P. Van Schil, F. Van den Brande, and M. De Maeseneer Current outcome in patients with lung cancer and positive mediastinoscopy Acta Chir Belg 101 2001 273 276
20. K.S. Albain, S. Swann, V.R. Rusch, T. Turrisi, A. Shepherd, C.J. Smith, D.R. Gandara, D.H. Johnson, M.R. Green, and R.C. Miller Phase III study of concurrent chemotherapy and radiotherapy (CT/RT) vs CT/RT followed by surgical resection for stage IIIA(pN2) non-small cell lung cancer (NSCLC): outcomes update of North American Intergroup 0139 RTOG 9309 J Clin Oncol 23 2005 16S (abstract 7014)
21. D.C. Betticher, S.F. Hsu Schmitz, M. Totsch, E. Hansen, C. Joss, C. von Briel, R.A. Schmid, M. Pless, J. Habicht, A.D. Roth, A. Spiliopoulos, R. Stahel, W. Weder, R. Stupp, F. Egli, M. Furrer, H. Honegger, M. Wernli, T. Cerny, and H.B. Ris Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial J Clin Oncol 21 2003 1752 1759